Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 11,058 | 14,681 | 18,210 | 16,928 | 0 |
| Gross Profit | 11,058 | 14,681 | 18,210 | 16,928 | N/A |
| Operating Expenses | 18,403 | 18,671 | 21,082 | 16,114 | 0 |
| Operating Income | -7,344 | -3,990 | -2,873 | 814 | N/A |
| Interest Expense | 66 | 79 | 74 | 75 | 0 |
| Other Income | -4,141 | 8 | 5 | 671 | 0 |
| Pre-tax Income | -11,552 | -4,061 | -2,942 | 1,410 | 0 |
| Net Income Continuous | -11,552 | -4,061 | -2,942 | 1,410 | N/A |
| Net Income | $-11,552 | $-4,061 | $-2,942 | $1,410 | $N/A |
| EPS Basic Total Ops | -4.10 | -1.60 | -1.10 | 0.50 | N/A |
| EPS Basic Continuous Ops | -4.12 | -1.56 | -1.13 | 0.54 | N/A |
| EPS Diluted Total Ops | -4.10 | -1.60 | -1.10 | 0.50 | N/A |
| EPS Diluted Continuous Ops | -4.08 | -1.56 | -1.13 | 0.50 | N/A |
| EBITDA(a) | $-6,683 | $-3,575 | $-2,572 | $1,091 | $N/A |